According to Zhitong Finance App, Cinda Biotech (01801.HK) announced that its partner Ollin Biosciences, Inc. (Ollin) has reached an acquisition agreement with Johnson & Johnson (NYSE: JNJ). The Ollin core pipeline OLN324 (Cinda Biotech R&D code: IBI324) was developed by Cinda Biotech and authorized to the outside world.

Zhitongcaijing · 1d ago
According to Zhitong Finance App, Cinda Biotech (01801.HK) announced that its partner Ollin Biosciences, Inc. (Ollin) has reached an acquisition agreement with Johnson & Johnson (NYSE: JNJ). The Ollin core pipeline OLN324 (Cinda Biotech R&D code: IBI324) was developed by Cinda Biotech and authorized externally.